Announcements Trials
Browse Landscape

Phase

Phase NA 36Phase 2 5Phase 3 4Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1COVID-19 1

Interventions

pembrolizumab 69Nivolumab 39Cyclophosphamide 35Carboplatin 27Dexamethasone 23Specimen Handling 22Paclitaxel 22Lenalidomide 22durvalumab 20Radiotherapy 19Gemcitabine 19venetoclax 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Rituximab 16Ipilimumab 16fludarabine 15Bevacizumab 15Biopsy 14atezolizumab 13Etoposide 13Vincristine 12Cisplatin 12Azacitidine 12belantamab mafodotin 11Pemetrexed 11Docetaxel 11Calcium Dobesilate 11olaparib 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × Practice Guidelines as Topic × Clear all
NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡